Logo

Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Ex...

TOKYO, Aug. 22, 2019 /PRNewswire-AsiaNet/ -- Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the treatment of depression in Japan, with the trials expected to begin soon...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660